Abstract:Background: Currently, no satisfactory biomarkers are available to screen for lung cancer. Surface-Enhanced Laser Desorption/ionization Time-of- Flight Mass Spectrometry ProteinChip system (SELDI-TOF-MS) is one of the currently used techniques to identify biomarkers for cancers. The aim of this study is to explore the application of serum SELDI proteomic patterns to distinguish lung cancer patients from healthy individuals.Methods: A total of 208 serum samples, including 158 lung cancer patients and 50 healthy individuals, were randomly divided into a training set (including 11 sera from patients with stages I/II lung cancer, 63 from patients with stages III/IV lung cancer and 20 from healthy controls) and a blinded test set (including 43 sera from patients with stages I/II lung cancer, 41 from patients with stages III/IV lung cancer and 30 from healthy controls). All samples were analyzed by SELDI technology. The spectra were generated on weak cation exchange (WCX2) chips, and protein peaks clustering and classification analyses were made using Ciphergen Biomarker Wizard and Biomarker Pattern software, respectively. We additionally determined Cyfra21-1 and NSE in the 208 serum samples included in this study using an electrochemiluminescent immunoassay.Results: Five protein peaks at 11493, 6429, 8245, 5335 and 2538 Da were automatically chosen as a biomarker pattern in the training set. When the SELDI marker pattern was tested with the blinded test set, it yielded a sensitivity of 86.9%, a specificity of 80.0% and a positive predictive value of 92.4%. The sensitivities provided by Cyfra21-1 and NSE used individually or in combination were significantly lower than that of the SELDI marker pattern (P < 0.005 or 0.05, respectively). Based on the results of the test set, we found that the SELDI marker pattern showed a sensitivity of 91.4% in the detection of non-small cell lung cancers (NSCLC), which was significantly higher than that in the detection of small cell lung cancers (P < 0.05); The pattern also had a sensitivity of 79.1% in the detection of lung cancers in stages I/II.Conclusion: These results suggest that serum SELDI protein profiling can distinguish lung cancer patients, especially NSCLC patients, from normal subjects with relatively high sensitivity and specificity, and the SELDI- TOF- MS is a potential tool for the screening of lung cancer.

[Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique]

Diagnosis of pancreatic adenocarcinoma using protein chip technology.

Evaluation of the Effectiveness of a Chemoprevention Model of Pancreatic Adenocarcinoma Using Protein Chip Technology.

Application of Seldi-Tof-Ms Coupled with an Artificial Neural Network Model to the Diagnosis of Pancreatic Cancer

Screening for Protein Markers from Serum of Patients with Pancreatic Carcinoma by Protein Finger Printing Technique

Construction of protein profiling models for diagnosis of pancreatic carcinoma

Application of Serum Seldi Proteomic Patterns in Diagnosis of Lung Cancer

[A Predictive Model for Pancreatic Cancer Using Serum Protein Footprint Map].

A Serum Proteomic Pattern for the Detection of Colorectal Adenocarcinoma Using Surface Enhanced Laser Desorption and Ionization Mass Spectrometry

Establishing Diagnostic Model of Serum Protein Fingerprinting Patterns for Henatic Metastasis of Coloretal Carcinoma and Its Clinical Application

Application of Serum Surface-Enhanced Laser Desorption/ionization Proteomic Patterns in Distinguishing Lung Cancer Patients from Healthy People.

Establishment of Serum Protein Pattern for Screening Colorectal Cancer Using SELDI-TOF-MS.

Prediction Of Pancreatic Cancer By Serum Biomarkers Using Surface-Enhanced Laser Desorption/Ionization-Based Decision Tree Classifi Cation

[The contribution for the diagnosis of the tumor-like polypoid lesions of the gallbladder by SELDI-TOF-MS]

[Establish Predictive Model of Colorectal Cancer by Using Surface Enhanced Laser Desorption/ionization-Time of Flight-Mass Spectrometry].

Screening Serum Biomarkers for Pancreatic Cancer by Serum Proteomics Techniques

Identification of Serum Biomarkers for Lung Cancer Using Magnetic Bead-Based Seldi-Tof-Ms

[Proteomic Analysis of Prostate Cancer Using Surface Enhanced Laser Desorption/ionization Mass Spectrometry].

SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer.

Differential Expression of Proteomics Models of Colorectal Cancer, Colorectal Benign Disease and Healthy Controls

Application of Surface-Enhanced Laser Desorption/ionization Time-of-flight-based Serum Proteomic Array Technique for the Early Diagnosis of Prostate Cancer